D M Moore|P H Raven - JoVE Visualize

Showing results (71-80 of 109) with videos related to

Pageof 11

Sort By:

American Journal of Ophthalmology|August 15, 1985

Solitary eosinophilic granuloma of the lateral orbital wallR B Feldman, D M Moore, C I Hood, et al.

JAMA|October 24, 1990

Changing the needle when inoculating blood cultures. A no-benefit and high-risk procedureM K Leisure, D M Moore, J D Schwartzman, et al.

Plos One|September 13, 2018

Hybridization in bottlenose dolphins-A case study of Tursiops aduncus × T. truncatus hybrids and successful backcross hybridization eventsT Gridley, S H Elwen, G Harris, et al.

Journal of Virology|October 1, 1987

Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcriptsV N Vakharia, M A Devaney, D M Moore, et al.

Veterinary Microbiology|May 1, 1982

Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VPH L Bachrach, D O Morgan, P D McKercher, et al.

Immunology|July 1, 1993

Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodiesM V Borca, A E Garmendia, B Baxt, et al.

HIV Medicine|August 15, 2006

CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microLD M Moore, R S Hogg, B Yip, et al.

HIV Medicine|September 2, 2006

Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapyD M Moore, R S Hogg, B Yip, et al.

The Laryngoscope|July 1, 1987

Laryngeal modeling: theoretical, in vitro, in vivoG S Berke, D M Moore, D R Hantke, et al.

Virus Research|May 1, 1989

Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypesJ C Saiz, M J Gonzalez, D O Morgan, et al.

Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:

Pageof 11

American Journal of Ophthalmology|August 15, 1985

Solitary eosinophilic granuloma of the lateral orbital wallR B Feldman, D M Moore, C I Hood, et al.

JAMA|October 24, 1990

Changing the needle when inoculating blood cultures. A no-benefit and high-risk procedureM K Leisure, D M Moore, J D Schwartzman, et al.

Plos One|September 13, 2018

Hybridization in bottlenose dolphins-A case study of Tursiops aduncus × T. truncatus hybrids and successful backcross hybridization eventsT Gridley, S H Elwen, G Harris, et al.

Journal of Virology|October 1, 1987

Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcriptsV N Vakharia, M A Devaney, D M Moore, et al.

Veterinary Microbiology|May 1, 1982

Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VPH L Bachrach, D O Morgan, P D McKercher, et al.

Immunology|July 1, 1993

Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodiesM V Borca, A E Garmendia, B Baxt, et al.

HIV Medicine|August 15, 2006

CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microLD M Moore, R S Hogg, B Yip, et al.

HIV Medicine|September 2, 2006

Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapyD M Moore, R S Hogg, B Yip, et al.

The Laryngoscope|July 1, 1987

Laryngeal modeling: theoretical, in vitro, in vivoG S Berke, D M Moore, D R Hantke, et al.

Virus Research|May 1, 1989

Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypesJ C Saiz, M J Gonzalez, D O Morgan, et al.

Pageof 11